To learn more about how Thailand plans to build its precision oncology ecosystem, Lab Insights spoke with Prof Manop Pithukpakorn, a physician and geneticist who works in the Faculty of Medicine in Siriraj Hospital at Mahidol University, Thailand. Prof Manop shares insights from his experiences with the Siriraj Centre of Research Excellence in Precision Medicine […]
Genomic studies have transformed our understanding of cancer, putting us on a path toward treating cancer based on its molecular profile rather than its site of origin. One of the most important advances has been the development of comprehensive genomic profiling (CGP), a test that can be run in clinical laboratories or outsourced to service
Is comprehensive genomic profiling right for your lab? Read More »
This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. Across the Asia Pacific region, growing use of next-generation sequencing (NGS) in clinical laboratories is driving major
Molecular tumour boards in Asia: turning NGS data into actionable cancer plans Read More »
This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. With over a million new cancer cases diagnosed annually in India, this country has a serious need
NGS and precision oncology in India: insights from Dr Amit Rauthan Read More »
This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. In 2020, Taiwan’s National Development Council forecasted that its people would reach ‘super-aged’ status by 2025. Since
Thanks to its availability and affordability, next-generation sequencing (NGS) has been an integral component of the scientific community’s response to the COVID-19 pandemic. Genomic data has enabled unprecedented pathogen surveillance and rapid development of diagnostic tests and vaccines based on the viral genome sequence. The very first look at the SARS-CoV-2 genome came from scientists
How NGS tools have shaped the COVID-19 pandemic response Read More »
This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. In 2018, the Australian government committed $500 million over 10 years for genomic research. With the vast
This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. In 2017, the Korean government began to provide selective health insurance coverage so that next-generation sequencing (NGS)
NGS and precision oncology in South Korea: insights from Prof Kim Jee-Hyun Read More »
This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. Cancer is a high-priority disease in Hong Kong, but although treatment success can be improved with next-generation
NGS and precision oncology in Hong Kong: insights from Dr Lam Tai-Chung Read More »
If you’ve been to the eye doctor recently, chances are good that your visit did not include any kind of test that had to be run in a clinical laboratory. Most rudimentary eye tests, such as for glaucoma, can be performed right in the doctor’s office. But pathology — molecular pathology, in particular — is
Calling all molecular pathologists: ophthalmologists need your help Read More »
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
